Funding – Talk Bio

Actionable Insights Powered by AI

Biopharma Bites: Teva, Kinaset Funding Wins, Camzyos Teen Approval, Lynk and Lyra’s Mixed Fortunes

1 day ago talkbio0Tagged approvals, Biopharma, Camzyos, Clinical, Funding, Kinaset, Lynk, Structure of hippocampal commissure, Teva

Teva; Kinaset; Camzyos; Lynk; Lyra; biopharma funding; clinical approvals

Kinaset Therapeutics Raises $103M to Advance Inhaled Asthma Drug

2 days ago talkbio0Tagged asthma drug, Funding, inhaled therapy, Kinaset Therapeutics, Series A

Kinaset Therapeutics; funding; asthma drug; inhaled therapy; Series A

VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026

6 days ago talkbio0Tagged 2026, AI-driven, Attitude, Funding, Investments, IPO, M&A activity, MassBio, rates, venture capital, Vital capacity, Window (physical object)

venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment

VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026

6 days ago talkbio0Tagged 2026, AI-driven, Attitude, Funding, Investments, IPO, M&A activity, MassBio, rates, venture capital, Vital capacity, Window (physical object)

venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment

VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026

6 days ago talkbio0Tagged 2026, AI-driven, Attitude, Funding, Investments, IPO, M&A activity, MassBio, rates, venture capital, Vital capacity, Window (physical object)

venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment

VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026

6 days ago talkbio0Tagged 2026, AI-driven, Attitude, Funding, Investments, IPO, M&A activity, MassBio, rates, venture capital, Vital capacity, Window (physical object)

venture capital; VC funding; 2025 H2; 2026 outlook; biotech; MassBio; IPO window; M&A activity; interest rates; AI-driven investment

Corsera Health Launches with $50M Funding for Preventive Cardiovascular RNAi Program Advancing to Clinic

6 days ago talkbio0Tagged Ambulatory Care Facilities, Cardiovascular Diseases, Corsera Health, Funding, Preventive Health Programs, RNAi medicine, trials

Corsera Health; cardiovascular disease; RNAi medicine; preventive program; clinic trials; funding; $50M

US Commits $480-487 Million in Health Funding to Ivory Coast Under ‘America First’ Health Strategy

2 weeks ago talkbio0Tagged Americas, COAST, deals, Funding, global health security, Health, HIV, Ivory, Malaria, Tuberculosis, U.S.

US Ivory Coast health agreement; America First health deals; $487 million funding; HIV malaria tuberculosis; global health security

Moderna Lands CEPI as New Backer for Its Pandemic Flu (H5 Bird Flu) Program

4 weeks ago talkbio0Tagged CEPI, coalition, Epidemic Preparedness Innovations, Funding, H5 bird flu, Moderna, mRNA Vaccine, pandemic influenza, pandemic preparedness, Phase 3 trial, Vaccine Development

Moderna; CEPI; Coalition for Epidemic Preparedness Innovations; pandemic influenza; H5 bird flu; mRNA vaccine; Phase 3 trial; pandemic preparedness; vaccine development; funding

Models are out, molecules are in as AI drug startups sprint to the clinic

4 weeks ago talkbio0Tagged Absci, AI drug discovery, AI-designed molecules, Clinical Trials, clinical-stage AI startups, Funding, Insilico Medicine, PsiThera, Recursion Pharmaceuticals, small molecule therapeutics

AI drug discovery; AI-designed molecules; clinical-stage AI startups; small-molecule therapeutics; biotech funding; Insilico Medicine; Recursion Pharmaceuticals; Absci; PsiThera; clinical trials